
Neurointerventional Medical Device Developer
Huajian Medical (01931.HK) announced that the company will hold a board meeting on March 18, 2022 (Friday) to consider and approve the group's annual results for the year ended December 31, 2021, and the payment of a final dividend (if any), as well as to deal with any other matters.